• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点在癌症转移过程中的多样化功能。

Varied functions of immune checkpoints during cancer metastasis.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, 5166614766, Tabriz, Iran.

Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

出版信息

Cancer Immunol Immunother. 2021 Mar;70(3):569-588. doi: 10.1007/s00262-020-02717-2. Epub 2020 Sep 9.

DOI:10.1007/s00262-020-02717-2
PMID:32902664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907026/
Abstract

Immune checkpoints comprise diverse receptors and ligands including costimulatory and inhibitory molecules, which play monumental roles in regulating the immune system. Immune checkpoints retain key potentials in maintaining the immune system homeostasis and hindering the malignancy development and autoimmunity. The expression of inhibitory immune checkpoints delineates an increase in a plethora of metastatic tumors and the inhibition of these immune checkpoints can be followed by promising results. On the other hand, the stimulation of costimulatory immune checkpoints can restrain the metastasis originating from diverse tumors. From the review above, key findings emerged regarding potential functions of inhibitory and costimulatory immune checkpoints targeting the metastatic cascade and point towards novel potential Achilles' heels of cancer that might be exploited therapeutically in the future.

摘要

免疫检查点包括多种受体和配体,包括共刺激和抑制分子,它们在调节免疫系统方面发挥着重要作用。免疫检查点在维持免疫系统的平衡和抑制恶性肿瘤的发展和自身免疫方面保留了关键的潜力。抑制性免疫检查点的表达表明了大量转移性肿瘤的增加,而抑制这些免疫检查点可以带来有希望的结果。另一方面,共刺激免疫检查点的刺激可以抑制来自不同肿瘤的转移。从上述综述中,可以发现针对转移级联的抑制性和共刺激免疫检查点的潜在功能的关键发现,并指出了癌症的新的潜在弱点,这些弱点可能在未来被用于治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9d/10991201/f15f65829bb1/262_2020_2717_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9d/10991201/fdb4f99e0579/262_2020_2717_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9d/10991201/f15f65829bb1/262_2020_2717_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9d/10991201/fdb4f99e0579/262_2020_2717_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9d/10991201/f15f65829bb1/262_2020_2717_Fig2_HTML.jpg

相似文献

1
Varied functions of immune checkpoints during cancer metastasis.免疫检查点在癌症转移过程中的多样化功能。
Cancer Immunol Immunother. 2021 Mar;70(3):569-588. doi: 10.1007/s00262-020-02717-2. Epub 2020 Sep 9.
2
Not All Immune Checkpoints Are Created Equal.并非所有免疫检查点都是平等的。
Front Immunol. 2018 Aug 31;9:1909. doi: 10.3389/fimmu.2018.01909. eCollection 2018.
3
Significance of TIM3 expression in cancer: From biology to the clinic.TIM3 表达在癌症中的意义:从生物学到临床。
Semin Oncol. 2019 Aug-Oct;46(4-5):372-379. doi: 10.1053/j.seminoncol.2019.08.005. Epub 2019 Nov 6.
4
Chemokines and cancer: new immune checkpoints for cancer therapy.趋化因子与癌症:癌症治疗的新免疫检查点。
Curr Opin Immunol. 2018 Apr;51:140-145. doi: 10.1016/j.coi.2018.03.004. Epub 2018 Mar 24.
5
Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy.隐匿于黑暗之中:CD40 在免疫检查点阻断治疗中的表达及临床相关性的泛癌特征分析。
Mol Cancer. 2021 Nov 10;20(1):146. doi: 10.1186/s12943-021-01442-3.
6
Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities.癌症免疫治疗后的不良反应:挑战与机遇。
Trends Immunol. 2019 Jun;40(6):511-523. doi: 10.1016/j.it.2019.04.002. Epub 2019 Apr 30.
7
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.调节任性的 T 细胞:免疫检查点抑制剂治疗在自身免疫、移植和癌症中的新前景。
J Autoimmun. 2020 Dec;115:102546. doi: 10.1016/j.jaut.2020.102546. Epub 2020 Sep 24.
8
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.黑色素瘤对免疫检查点抑制剂反应的生物学因素。
Int J Mol Sci. 2020 Jun 6;21(11):4071. doi: 10.3390/ijms21114071.
9
Immune checkpoint therapy in liver cancer.肝癌的免疫检查点治疗。
J Exp Clin Cancer Res. 2018 May 29;37(1):110. doi: 10.1186/s13046-018-0777-4.
10
Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade.表观遗传学调节对免疫检查点阻断反应的复杂性。
EBioMedicine. 2020 Oct;60:103005. doi: 10.1016/j.ebiom.2020.103005. Epub 2020 Sep 26.

引用本文的文献

1
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
2
Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface.绘制T细胞活化蛋白表面V结构域免疫球蛋白抑制因子上的结合热点和瞬时结合口袋。
ACS Omega. 2024 Nov 23;9(49):48657-48669. doi: 10.1021/acsomega.4c07757. eCollection 2024 Dec 10.
3

本文引用的文献

1
Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling.腺苷与腺苷受体 A2a 的相互作用通过增强 PI3K-AKT-mTOR 信号通路促进胃癌转移。
Mol Biol Cell. 2019 Sep 1;30(19):2527-2534. doi: 10.1091/mbc.E19-03-0136. Epub 2019 Jul 24.
2
Concurrent Expression of CD47 and CD44 in Colorectal Cancer Promotes Malignancy.结直肠癌中 CD47 和 CD44 的共表达促进恶性肿瘤的发生。
Pathobiology. 2019;86(4):182-189. doi: 10.1159/000496027. Epub 2019 May 27.
3
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
The Silent Threat of Interplay between Immune Checkpoint Inhibitors and Herbal Medicines.
免疫检查点抑制剂与草药之间相互作用的潜在威胁
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3337-3338. doi: 10.31557/APJCP.2024.25.10.3337.
4
IQGAP3 promotes the progression of glioma as an immune and prognostic marker.IQGAP3 作为一种免疫和预后标志物促进神经胶质瘤的进展。
Oncol Res. 2024 Mar 20;32(4):659-678. doi: 10.32604/or.2023.046712. eCollection 2024.
5
Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival.泛癌症分析 FANCD2 的预后和免疫作用:致癌和生存的潜在靶点。
BMC Med Genomics. 2024 Mar 5;17(1):69. doi: 10.1186/s12920-024-01836-4.
6
Progress of immunotherapies in gestational trophoblastic neoplasms.免疫疗法在妊娠滋养细胞肿瘤中的进展。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15275-15285. doi: 10.1007/s00432-023-05010-8. Epub 2023 Aug 18.
7
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.一种与铁死亡相关的长链非编码RNA特征可预测结肠腺癌的预后。
Life (Basel). 2023 Jul 13;13(7):1557. doi: 10.3390/life13071557.
8
Silencing of LINC00467 inhibits cell proliferation in testicular germ cell tumors cells.LINC00467 的沉默抑制睾丸生殖细胞肿瘤细胞的增殖。
Biomol Biomed. 2023 Sep 4;23(5):802-814. doi: 10.17305/bb.2023.8969.
9
Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.Stonin1 基因与肿瘤免疫微环境的关系及其对肾透明细胞癌免疫检查点阻断和靶向治疗预测价值的综合分析。
BMC Cancer. 2023 Feb 9;23(1):135. doi: 10.1186/s12885-023-10616-9.
10
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.结直肠癌中的免疫检查点抑制剂:挑战与未来前景
Biomedicines. 2021 Aug 24;9(9):1075. doi: 10.3390/biomedicines9091075.
CD73 通过诱导 Rap1 介导的 P110β 膜定位来激活 PI3K/AKT 信号通路,促进肝癌的进展和转移,并预测预后不良。
J Hematol Oncol. 2019 Apr 11;12(1):37. doi: 10.1186/s13045-019-0724-7.
4
CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.CBX8 和 CD96 是结直肠癌的重要预后生物标志物。
Med Sci Monit. 2018 Nov 1;24:7820-7827. doi: 10.12659/MSM.908656.
5
CD73 expression and clinical significance in human metastatic melanoma.CD73在人类转移性黑色素瘤中的表达及临床意义
Oncotarget. 2018 Jun 1;9(42):26659-26669. doi: 10.18632/oncotarget.25426.
6
Next generation of immune checkpoint therapy in cancer: new developments and challenges.癌症免疫检查点治疗的新一代:新进展与新挑战。
J Hematol Oncol. 2018 Mar 15;11(1):39. doi: 10.1186/s13045-018-0582-8.
7
Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma.NKT 细胞上 BTLA 的下调促进乳腺癌小鼠模型中的肿瘤免疫控制。
Int J Mol Sci. 2018 Mar 7;19(3):752. doi: 10.3390/ijms19030752.
8
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.LAG-3 在非小细胞肺癌中的表达:原发肿瘤和转移淋巴结中的表达与生存改善相关。
Clin Lung Cancer. 2018 May;19(3):249-259.e2. doi: 10.1016/j.cllc.2017.12.001. Epub 2017 Dec 11.
9
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
10
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.A2AR 腺苷信号抑制肿瘤微环境中自然杀伤细胞的成熟。
Cancer Res. 2018 Feb 15;78(4):1003-1016. doi: 10.1158/0008-5472.CAN-17-2826. Epub 2017 Dec 11.